KF-27376

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameKF-27376
Drug Alias Name6-MethylstaurosporinKF-27376
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase C inhibitorsThrombopoietin receptor agonists
TargetsProtein kinase CThrombopoietin receptor
Therapy Area/IndicationsLeukopeniaThrombocytopenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKyowa Hakko Kogyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKyowa Hakko Kogyo Co Ltd
Active IndicationsN/A
Inactive IndicationsLeukopeniaThrombocytopenia

Other Information

ATC CodeN/A
Related LinksN/A